EurekaMag.com logo
+ Translate

Canine pyoderma: symptomatology and therapy with special regard to a new cephalosporin preparation (Cephalexin-monohydrate)


, : Canine pyoderma: symptomatology and therapy with special regard to a new cephalosporin preparation (Cephalexin-monohydrate). Kleintierpraxis 35(9): 483-492

From November 1986 to August 1988 54 dogs (German Shepherds, half-breed dogs and rough-haired Dachshunds) with pyoderma were treated with a new cephalosporin preparation Cephalexin-monohydrate (Cefaseptin/Chassot). 31 patients were healed completely, a further seven only after a second treatment of relapses. 13 patients showed permanent relapses after each treatment with only incomplete healing while the treatment was unsuccessful in one case.

(PDF 0-2 workdays service)

Accession: 002042617

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Sprucek, F.; Svoboda, M.; Toman, M.; Faldyna, M.; Sprucek, F.J., 2007: Therapy of canine deep pyoderma with cephalexin and immunomodulators. Pyodermas are among the bacterial skin diseases often resisting antibiotic therapy. We therefore examined how dogs with deep pyoderma (n=29) respond to therapy with cephalexin (CeporexReg. 30 mg/kg p.o., once a day for 9-11 weeks) combined with an...

Guaguere, E.; Salomon, C.; Maynard, L., 1998: Using cephalexin in the treatment of canine pyoderma. Comparing the efficacy of different dosages. Both controlled and randomised studies were carried out on 165 dogs to demonstrate the clinical efficacy of cephalexin compared with Amoxicillin-clavulanic acid (ACA). Cephalexin (30 mg kg-1 day-1) treatment of superficial pyodermas resulted in 93...

Wojtacha-Wencel, B.; Urbańska, D.; Wojnar, J., 1982: Clinical evaluation of the preparation Palitrex (cephalexin monohydrate). Wiadomosci Lekarskie 35(6): 385-390

Toma, S.; Colombo, S.; Cornegliani, L.; Persico, P.; Galzerano, M.; Gianino, M.M.; Noli, C., 2008: Efficacy and tolerability of once-daily cephalexin in canine superficial pyoderma: an open controlled study. Objectives: The aims of this study were to evaluate the efficacy and tolerability of oral cephalexin given at 30 mg/kg once daily in dogs with superficial pyoderma and to compare them with those of oral cephalexin given at 15 mg/kg twice daily. Me...

Bousquet, E.; Ganiere, J.P.; Ruvoen, N.; Larrat, M., 1999: Post-antibiotic effect of cephalexin against isolates of Staphylococcus intermedius obtained from cases of canine pyoderma. The post-antibiotic effect (PAE) in vitro of cephalexin was determined according to a broth dilution method against 5 isolates of S. intermedius obtained from cases of canine pyoderma in France in 1997. Two durations of exposure and 3 concentratio...

Sugihara, Y.; Uga, T.; Tsunoda, T.; Makimoto, Y.; Hirai, S., 1971: Chemotherapy of biliary infection--with special reference to transport of cephalosporin antibiotic, cephalexin, into the bile. Saishin Igaku. Modern Medicine 26(10): 1996-2001

Kumar, A.; Murray, D.L.; Hanna, C.B.; Kreindler, T.G.; Jacobson, K.D.; Bundy, J.M.; Waxman, K.; Finnerty, E.F.; Folan, D.W.; Drucker, W.R., 1988: Comparative study of cephalexin hydrochloride and cephalexin monohydrate in the treatment of skin and soft tissue infections. In two prospective, randomized multicenter double-blind studies with a dosage of either 250 mg given four times a day (study A) or 500 mg given two times a day (study B), the comparative efficacy and safety of cephalexin hydrochloride (LY061188; K...

Gravino, A.E.; Cerundolo, R.; Agresti, A., 1990: Use of cephalexin in the oral therapy of deep pyoderma in dogs. Bacteriological examination of the lesions of 10 dogs (six were German Shepherds) with severe pyoderma that had not responded to antibiotic and cortisone therapy resulted in the isolation of Staphylococcus intermedius (6 dogs) and S. aureus (4 dog...

Zabransky, R.J.; Gardner, M.A.; Geraci, J.E., 1969: Cephalexin: preliminary in vitro studies of a new orally administered cephalosporin and report of a case of endocarditis cured with cephalexin. Mayo Clinic Proceedings 44(12): 876-885

Sztankay, C., 1967: General problems of vasodilator therapy with special regard to bupatol, a new angiolytic preparation. Therapia Hungarica 15(1): 27-32